Sagent Pharmaceuticals news from FierceBiotech
NewsSpectrum sells off generic drugs
Specturm Pharmaceuticals has sold its abbreviated NDAs for its injectable generic drugs, ondansetron, carboplatin, fludarabine, and mitoxantrone, to Read more...
Sagent Pharmaceuticals - Top 20 VC deals of 2007
Company: Sagent Pharmaceuticals Based: Schaumburg, IL Amount: $53M Round: First Investors: Capricorn Management, Vivo Ventures Scoop: Read more...
Start-ups snare big rounds of venture funds
Sagent Pharmaceuticals has lined up $53 million in venture financing, a big first round for the start-up based in Schaumburg, IL. Vivo Ventures led the round for Sagent, which was launched in 2006. Read more...
| Press ReleasesPRESS RELEASE: Sagent Pharmaceuticals Inc. Completes $53 Million Series A Financing Sagent Pharmaceuticals Inc. Completes $53 Million Series A Financing SCHAUMBURG, Ill., September 27, 2007 -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company today Read more... |
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends